SBRT for primary inoperable NSCLC and secondary lung and adrenal lesions in 121 oligometastatic patients

被引：0
|
作者：
Tubin, S. [1 ]
Casamassima, F. [1 ]
Menichelli, C. [1 ]
Fanelli, A. [1 ]
Grespi, S. [1 ]
Pastore, G. [1 ]
Arrichiello, C. [1 ]
Ferullo, A. [1 ]
机构：
[1] Ctr Radioterapia Ecomed, Radiotherapy, Empoli, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2015年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1176
引用
收藏
页码：S639 / S640
页数：2
相关论文
共 50 条
  • [41] Outcomes after SBRT for Inoperable Early Stage Lung Cancers Arising in Organ Transplant Patients
    Fleming, C. W.
    Stephans, K. L.
    Broughman, J. R.
    Rybicki, L.
    Budev, M.
    Ahmad, U.
    Videtic, G. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E486 - E486
  • [42] Diffusion Weighted MRI for Response Assessment of Inoperable Lung Tumors for Patients Undergoing SBRT Treatment
    Tyagi, N.
    Wengler, K.
    Yorke, E.
    Hunt, M.
    Deasy, J.
    Rimner, A.
    MEDICAL PHYSICS, 2014, 41 (06) : 519 - 519
  • [43] Treatment Outcome and the Role of Primary Tumor Therapy in a Cohort of Patients with Synchronous Oligometastatic NSCLC
    Carlos Ruffinelli, Jose
    Navarro-Martin, Arturo
    Domenech, Marta
    Palmero, Ramon
    Padrones, Susana
    Arnaiz, Ma Dolores
    Aso, Samantha
    Ramos, Ricard
    Macia, Ivan
    Plana, Maria
    Mesia, Carles
    Rivas, Francisco
    Andia, Eduard
    Conejero, Ariadna
    Luis Vercher, Jose
    Brao, Isabel
    Arellano, Monica
    Cardenal, Felipe
    Nada, Ernest
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S962 - S962
  • [44] Gating strategy selection for patients with apical lung lesions in MRgRT SBRT
    Galetto, M.
    Nardini, M.
    Capotosti, A.
    Boldrini, L.
    Chiloiro, G.
    Romano, A.
    Votta, C.
    Indovina, L.
    Placidi, L.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1630 - S1631
  • [45] Long Term Clinical Outcomes of a Cohort of Lung-Only Oligometastatic HNSCC Patients Treated with SBRT
    Salvestrini, V.
    Becherini, C.
    Desideri, I.
    Simontacchi, G.
    Loi, M.
    Garlatti, P.
    Bertini, N.
    Bonaparte, I.
    Mattioli, C.
    Banini, M.
    Morelli, I.
    Meattini, I.
    Bonomo, P.
    Livi, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E601 - E602
  • [46] A PHASE 2 STUDY OF DURVALUMAB COMBINED WITH CHEMOTHERAPY AND STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN PATIENTS WITH OLIGOMETASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) (SABRCURE TRIAL)
    Chen, Ming
    Ma, Honglian
    Du, Xianghui
    Xu, Yujin
    Ji, Yongling
    Song, Zhengbo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A729 - A729
  • [47] Stereotactic body radiotherapy in patients with adrenal gland metastases of oligometastatic and oliogoprogressive lung cancer
    Rzazade, Rashad
    Pham, Ngoc T.
    Turna, Menekse
    Canoglu, Mehmet Dogu
    Kucukmorkoc, Esra
    Berberoglu, Kezban
    Caglar, Hale Basak
    JOURNAL OF RADIOSURGERY AND SBRT, 2023, 8 (04): : 275 - 282
  • [48] Histology as predictor for outcome following SBRT in NSCLC patients with lung oligo-metastases
    Hoerner-Rieber, J.
    Abbasi-Senger, N.
    Blanck, O.
    Boda-Heggemann, J.
    Duma, M.
    Eble, M. J.
    Eich, H. T.
    Flentje, M.
    Gerum, S.
    Haas, P.
    Henkenberens, C.
    Hildebrandt, G.
    Imhoff, D.
    Kahl, H.
    Klass, N. D.
    Krempien, R.
    Lohaus, F.
    Petersen, C.
    Sackerer, I.
    Schrade, E.
    Uhlmann, L.
    Wittig, A.
    Guckenberger, M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S18 - S19
  • [49] Non-gated F-18 FDG PET/CT for target volume delineation in stereotactic body radiation therapy (SBRT) in patients with stage I non-small cell lung cancer (NSCLC) or hypermetabolic oligometastatic lung lesions
    Schmuecking, M.
    Klaeser, B.
    Toepfer, M.
    Malthaner, M.
    Blumstein, N.
    Frueh, M.
    Born, E.
    Broemme, J.
    Plasswilm, L.
    Krause, T.
    Aebersold, D. M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 70 - 70
  • [50] NON-GATED F-18 FDG PET/CT FOR TARGET VOLUME DELINEATION IN STEREOTACTIC BODY RADIATION THERAPY (SBRT) IN PATIENTS WITH STAGE I NON-SMALL CELL LUNG CANCER (NSCLC) OR HYPERMETABOLIC OLIGOMETASTATIC LUNG LESIONS
    Schmuecking, M.
    Klaeser, B.
    Toepfer, M.
    Malthaner, M.
    Blumstein, N.
    Frueh, M.
    Born, E.
    Bromme, J. O.
    Plasswilm, L.
    Krause, T.
    Aebersold, D. M.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S343 - S344
12345